D-W Kim Selected Research

D-W Kim Research Topics

Disease

17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 01/2004
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 12/2007
12	Neoplasms (Cancer) 01/2022 - 04/2007
7	Philadelphia Chromosome 01/2016 - 11/2004
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016 - 10/2009
5	Disease Progression 11/2022 - 03/2004
5	Blast Crisis (Blast Phase) 01/2017 - 09/2004
5	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2009 - 01/2004
3	Hypertension (High Blood Pressure) 11/2022 - 05/2015
3	Exanthema (Rash) 01/2022 - 05/2015
3	Rectal Neoplasms (Rectal Cancer) 01/2019 - 03/2006
3	Residual Neoplasm 01/2016 - 11/2012
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2015 - 08/2010
3	Infections 04/2007 - 03/2004
2	Fatigue 01/2022 - 05/2015
2	Osteoarthritis 12/2013 - 12/2013
2	Leukemia 11/2013 - 04/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2013 - 07/2009
2	Status Epilepticus (Complex Partial Status Epilepticus) 07/2011 - 03/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2005 - 08/2004
2	Hyperalgesia 01/2005 - 01/2004
1	Lymphopenia (Lymphocytopenia) 11/2022
1	Neutropenia 11/2022
1	Pruritus (Itching) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Disease Resistance 03/2018
1	Reperfusion Injury 03/2017
1	Inflammation (Inflammations) 03/2017
1	Ischemia 03/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2016
1	Peripheral Arterial Disease 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2015
1	Nausea 05/2015
1	Diarrhea 05/2015
1	Vomiting 05/2015
1	Asthenia 05/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2014
1	Osteolysis 12/2013
1	Hemorrhage 11/2013
1	Atopic Dermatitis (Atopic Eczema) 07/2013
1	Alopecia (Baldness) 07/2013

Drug/Important Bio-Agent (IBA)

17	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 01/2004
6	Dasatinib (BMS 354825)FDA Link 01/2016 - 12/2008
5	ErbB Receptors (EGF Receptor)IBA 02/2024 - 03/2008
5	nilotinib FDA Link 01/2016 - 07/2010
4	Tyrosine Kinase InhibitorsIBA 01/2017 - 01/2013
3	pembrolizumabIBA 01/2022 - 01/2019
3	CrizotinibIBA 01/2020 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
3	Docetaxel (Taxotere)FDA Link 01/2019 - 08/2009
3	Cisplatin (Platino)FDA LinkGeneric 08/2009 - 12/2007
2	Gefitinib (Iressa)FDA Link 01/2017 - 03/2016
2	AfatinibIBA 01/2017 - 03/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2016 - 12/2007
2	bcr-abl Fusion ProteinsIBA 08/2013 - 09/2006
2	Methotrexate (Mexate)FDA LinkGeneric 10/2009 - 01/2009
2	N 30IBA 10/2009 - 08/2009
2	Fluorouracil (Carac)FDA LinkGeneric 08/2009 - 03/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 04/2007 - 05/2005
1	Topoisomerase I InhibitorsIBA 02/2024
1	Immunoconjugates (Immunoconjugate)IBA 02/2024
1	patritumab deruxtecanIBA 02/2024
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2022
1	pralsetinibIBA 11/2022
1	ceritinibIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	alectinibIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2018
1	Aminophylline (Carine)FDA LinkGeneric 03/2017
1	vandetanib (ZD6474)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2016
1	Thymidylate SynthaseIBA 01/2016
1	AntigensIBA 07/2015
1	Interleukin-10 (Interleukin 10)IBA 07/2015
1	trametinibIBA 05/2015
1	ultra-high molecular weight polyethylene (UHMWPE)IBA 12/2013
1	Polyethylene (Polythene)IBA 12/2013
1	ponatinibIBA 11/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2013
1	AnticoagulantsIBA 11/2013

Therapy/Procedure

9	Therapeutics 11/2022 - 01/2009
7	Stem Cell Transplantation 10/2016 - 08/2004
7	Drug Therapy (Chemotherapy) 03/2016 - 11/2008
5	Transplantation 05/2013 - 05/2005
3	Hematopoietic Stem Cell Transplantation 05/2008 - 05/2002
2	Homologous Transplantation 11/2012 - 01/2009
1	Proctectomy 01/2019
1	Chemoradiotherapy 01/2019
1	Intraperitoneal Injections 03/2017
1	Nephrectomy 03/2017
1	Time-to-Treatment 01/2017
1	Aftercare (After-Treatment) 03/2016
1	Withholding Treatment 01/2016
1	Immunotherapy 07/2015
1	Mohs Surgery (Mohs' Micrographic Surgery) 10/2014
1	Arthroplasty 12/2013
1	Thrombolytic Therapy 11/2013
1	Complementary Therapies (Alternative Medicine) 07/2013